Interferon-ß Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial.

Schultheiss, Heinz-Peter; Bock, Claus-Thomas; Aleshcheva, Ganna; Baumeier, Christian; Poller, Wolfgang; Escher, Felicitas

Schultheiss, Heinz-Peter; Bock, Claus-Thomas; Aleshcheva, Ganna; Baumeier, Christian; Poller, Wolfgang; Escher, Felicitas.

Affiliation

Schultheiss HP; Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, 12203 Berlin, Germany.
Bock CT; Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.
Aleshcheva G; Institute of Tropical Medicine, University of Tuebingen, 72074 Tuebingen, Germany.
Baumeier C; Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, 12203 Berlin, Germany.
Poller W; Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, 12203 Berlin, Germany.
Escher F; Department of Cardiology, Campus Benjamin Franklin, Charité, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, 13353 Berlin, Germany.

Viruses ; 14(2)2022 02 21.

Article de En | MEDLINE | ID: mdl-35216037

Sujet(s)
Mots clés

human parvovirus B19; interferon beta-1b; transcriptional activity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Endothélium vasculaire / Parvovirus humain B19 / Interféron bêta / Infections à Parvoviridae / Cardiomyopathies Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Viruses Année: 2022 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google